Lifeboat Foundation

This image shows AAV therapy affecting pyramidal neurons in the hippocampus. Credit: Blake Albright, Asokan Lab Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses. UNC School of Medicine researchers have now found a structure on these viruses that makes them better at crossing from the bloodstream into the brain – a key factor for administering gene therapies at lower doses for treating brain and spinal disorders. This structural…